collaborators

The RDI is extremely grateful to all the following individuals and institutions for collaborating with the RDI.

  • Brian Agan (US Military HIV Research Program, Bethesda, USA)
  • Roos Barth (Ndlovu Medical Centre, Elandsdoorn, South Africa)
  • John Bartlett (CPCRA, Duke University Medical Center, Durham, USA)
  • John Baxter (GART, Cooper University Medical School, Camden, USA)
  • Mark Boyd (The Kirby Institute, University of New South Wales, Sydney, Australia)
  • Raffaella Bucciardini (Istituto Superiore di Sanità, Rome, Italy)
  • Andrew Carr (St. Vincent's Hospital, Sydney, NSW, Australia)
  • Carina Cesar (Fundacion Huesped, Buenos Aires, Argentina)
  • Bonaventura Clotet (Fundacion IrsiCaixa, Badelona)
  • David Cooper (CREST)
  • Alessandro Cozzi-Lepri (ICONA, c/0 University of Milan, Italy)
  • Marie-Pierre deBethune (Tibotec Pharmaceuticals)
  • Gabriella d'Ettorre (Sapienza University, Rome, Italy)
  • Robin Dewar (National Institutes of Allergy and Infectious Diseases)
  • Tobias Rinke de Wit (PASER-M cohort, The Netherlands)
  • Frank DeWolf (ATHENA database, Netherlands HIV Monitoring Foundation, Amsterdam, The Netherlands)
  • Ricardo Diaz (Federal University of Sao Paulo, Sao Paulo, Brazil)
  • Gordana Dragovic (University of Belgrade, Belgrade, Serbia)
  • Sean Emery (The Kirby Institute, University of New South Wales, Sydney, Australia)
  • Luminita Ene ('Dr. Victor Babes' Hospital for Infectious and Tropical Diseases, Bucharest, Romania)
  • Jose Gatell (Hospital Clinic Barcelona)
  • Brian Gazzard (Chelsea and Westminster Hospital, London)
  • Anna Maria Geretti (Royal Free Hospital, London, UK)
  • Raph Hamers (PharmAccess Foundation, AMC, Amsterdam, The Netherlands)
  • Richard Harrigan (BC Centre for Excellence in HIV/AIDS)
  • Karl Hesse (St. Vincent's Hospital, Sydney, NSW, Australia)
  • Chris Hoffmann (Aurum Institute, Johannesburg, South Africa)
  • Rolf Kaiser (AREVIR database, c/o the University of Cologne, Germany)
  • Mike Kozal (CPCRA)
  • Cliff Lane (National Institutes of Allergy and Infectious Diseases)
  • Jody Lawrence (CPCRA)
  • Elisa Lazzari (Hospital Clinic Barcelona)
  • Juan Sierra Madero (Instituto Nacional de Ciencias Medicas y Nutricion SZ, Mexico)
  • Vincent Marconi (US Military HIV Research Program, Bethesda, USA)
  • Julie Metcalf (PHIDISA study, c/o National Institutes of Allergy and Infectious Diseases, Bethesda, USA)
  • Michael Miller (Gilead Sciences, Foster City, USA)
  • Antonella Monforte (ICONA, c/0 University of Milan, Italy)
  • Laura Monno (PhenGen study, Italy)
  • Julio Montaner (BC Centre for Excellence in HIV/AIDS)
  • Carl Morrow (Desmond Tutu HIV Centre, Cape town, South Africa)
  • Mark Nelson (Chelsea and Westminster Hospital, London)
  • Richard Norris (St. Vincent's Hospital, Sydney, NSW, Australia)
  • Pascale Ondoa (PASER-M cohort, The Netherlands)
  • Maria-Jesus Perez-Elias (Ramon y Cajal Hospital, Madrid, Spain)
  • Gaston Picchio (Tibotec Pharmaceuticals)
  • Anton Pozniak (Chelsea and Westminster Hospital, London)
  • Peter Reiss (ATHENA database, Netherlands HIV Monitoring Foundation, Amsterdam, The Netherlands)
  • Jim Rooney (Gilead Sciences, Foster City, USA)
  • Lidia Ruiz (Fundacion IrsiCaixa, Badelona)
  • Rob Schuurman (PharmAccess Foundation, AMC, Amsterdam, The Netherlands)
  • Kim Sigaloff (PASER-M cohort, The Netherlands)
  • Ard van Sighem (ATHENA database, Netherlands HIV Monitoring Foundation, Amsterdam, The Netherlands)
  • Schlomo Staszewski (Hospital of the JW Goethe University, Frankfurt)
  • Adrian Streinu-Cercel (National Institute of Infectious Diseases Prof.Dr. Matei Balş, Bucharest, Romania)
  • Oana  Streinu-Cercel (National Institute of Infectious Diseases Prof.Dr. Matei Balş, Bucharest, Romania)
  • Cecilia Sucupira (Federal University of Sao Paulo, Sao Paulo, Brazil)
  • Omar Sued (Fundacion Huesped, Buenos Aires, Argentina)
  • Wataru Sugiura (National Institute of Infectious Diseases, Tokyo)
  • Catherine Tamalet (Hôpital Timone, Marseilles, France)
  • Hugo Tempelman (Ndlovu Medical Centre, Elandsdoorn, South Africa)
  • Carlo Torti (Italian MASTER Cohort c/o University of Brescia, Italy)
  • Gerardo Alvarez-Uria (Rural Development Trust (RDT) Hospital, Bathalapalli, India)
  • Stefano Vella (Istituto Superiore di Sanità, Rome, Italy)
  • Emanuel Vlahakis (Taylor's Square Private Clinic, Darlinghurst, NSW, Australia)
  • Scott Wegner (US Military HIV Research Program, Bethesda, USA)
  • Annemarie Wensing (University Medical Centre, Utrecht, The Netherlands)
  • Robin Wood (Desmond Tutu HIV Centre, Cape town, South Africa)
RDI

Join the RDI mailing list

Enter your email address below to start receiving the RDI newsletter.

You can unsubscribe at any time. View the RDI privacy policy.

Email